KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 2,835.00
-140.00 (-4.71%)
At close: Sep 3, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 56.51 billion as of September 4, 2026. Its market cap has decreased by -55.37% in one year.
Market Cap
56.51B
Enterprise Value
41.82B
Revenue
75.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,835.00
ChartMarket Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 56.51B, a decrease of -88.54%. That is a compound annual growth rate of -31.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 56.51B | -49.21% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Naturalendo Tech | 69.15B |
| ADBiotech | 67.78B |
| PanGen Biotech | 67.50B |
| Psomagen | 66.17B |
| NovMetaPharma | 62.80B |
| ABION | 60.91B |
| TegoScience | 60.45B |
| QuadMedicine | 56.26B |